MUIFX
Price
$33.97
Change
-$1.04 (-2.97%)
Updated
Dec 18 closing price
VSTSX
Price
$278.22
Change
-$9.02 (-3.14%)
Updated
Dec 18 closing price
Ad is loading...

MUIFX vs VSTSX

Header iconMUIFX vs VSTSX Comparison
Open Charts MUIFX vs VSTSXBanner chart's image
Nationwide Institutional Service
Price$33.97
Change-$1.04 (-2.97%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Instl Sel
Price$278.22
Change-$9.02 (-3.14%)
VolumeN/A
CapitalizationN/A
MUIFX vs VSTSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MUIFX vs. VSTSX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MUIFX is a Buy and VSTSX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.84T vs. MUIFX (1.77B). VSTSX pays higher dividends than MUIFX: VSTSX (1.36) vs MUIFX (0.41). MUIFX was incepted earlier than VSTSX: MUIFX (92 years) vs VSTSX (8 years). MUIFX is a more actively managed with annual turnover of: 72.63 vs. VSTSX (2.00). MUIFX has a lower initial minimum investment than VSTSX: MUIFX (50000) vs VSTSX (5000000000). MUIFX (22.93) and VSTSX (22.07) have marching annual gain over last year. VSTSX return over 5 years is better than : 77.59 vs. MUIFX (55.54).
MUIFXVSTSXMUIFX / VSTSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence92 years8 years-
Gain YTD25.13022.447112%
Front LoadN/AN/A-
Min. Initial Investment5000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.77B1.84T0%
Annual Yield % from dividends0.411.3630%
Returns for 1 year22.9322.07104%
Returns for 3 years7.2423.9330%
Returns for 5 years55.5477.5972%
Returns for 10 years67.97N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICHR31.23-0.50
-1.58%
Ichor Holdings
GEHC77.09-2.16
-2.73%
GE HealthCare Technologies
ABG243.51-8.79
-3.48%
Asbury Automotive Group
TRAK22.52-2.03
-8.27%
ReposiTrak
SABS3.34-0.69
-17.12%
SAB Biotherapeutics